News - MedTech & Diagnostics
Bupa cuts mental health costs as APHA demands psychiatrist reform

New government data shows a 67% increase in Australians avoiding mental healthcare because of cost. In response, Bupa has launched a low-cost offering through Mindplace during Mental Health Week.
Available to all Australians, regardless of private health insurance or Medicare status, Mindplace will cap fees at $129 per session with a registered psychologist and $175 per clinical psychologist. Both rates are less than half the fees suggested by the Australian Psychological Society Schedule of Suggested Fees. For people accessing care under a Medicare Mental Health Treatment plan, the initiative brings out-of-pocket costs to no more than $28 per session.
Glenn McPhee, Managing Director of Mindplace, Government and Corporate Health, said the initiative was designed to make ongoing psychological support more affordable at a time when cost-of-living pressures are forcing Australians to make difficult decisions about essential services.
“We continue to hear from clients who cannot afford ongoing mental health care due to cost-of-living pressures. This offer is about reducing barriers to care for more Australians and helping those who need to start or continue with their mental health care,” said McPhee.
The financial barriers are not affecting all Australians equally. Government data suggests people aged 25–34 experience the highest rate of cost-related avoidance of mental health support, at 24%. Women are also substantially more likely than men to forgo care on financial grounds, with avoidance rates of 23% compared with 15%.
“By expanding Mindplace’s network of mental health centres throughout metropolitan and regional areas, Bupa intends to play a pivotal role in meeting the increasing demand for mental health support in our community,” McPhee added. “Through the provision of low-cost options and a growing mental health workforce, our ambition is to work in partnership with the services already provided by the public system to ensure all Australians can access the mental health support they need.”
However, affordability is only one pressure point in a mental health system confronting a more acute capacity crisis. While lower-cost psychology sessions help more Australians access ongoing support, the availability of specialist psychiatric care remains a critical concern for patients whose condition requires hospitalisation.
The Australian Private Hospitals Association (APHA) has spent four years calling for the easing of a 10-year moratorium that restricts internationally trained psychiatrists already in Australia from working in private hospitals. The restriction is exacerbating workforce shortages at a time when private psychiatric services are struggling to meet demand.
“When somebody reaches the point where they need acute psychiatric care, telling them there is a six-to-12 month wait, that the psychiatrist isn’t taking new patients or that their local service has closed is not a mental health system that is working,” emphasised APHA CEO Brett Heffernan. “Private psychiatric hospitals have beds, specialist facilities and clinical teams are ready to care for severe-needs patients. Yet, they are turning away referrals for acute patients. What they don’t have are enough psychiatrists.”
Private hospitals provide 61% of the acute mental health care, treating patients whose conditions require hospitalisation, specialist psychiatric intervention and multidisciplinary clinical teams. A shortage of psychiatrists, the APHA argues, is preventing existing hospital capacity from being fully utilised, leaving patients without timely access to the level and quality of care they need.
“Free up the 300 psychiatrists we already have waiting in the wings. Keep private psychiatric hospitals viable. Address the funding and contracting crisis putting services at risk. And make sure Australians asking for mental health help can actually get it,” explained Heffernan. “If the hospital services patients rely on continue to close, we haven’t solved the problem. The cost of providing care is going up while funding has not kept pace. Psychiatric hospitals and units have closed, services have disappeared and patients and families are left trying to work out where to turn next.”
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News - MedTech & Diagnostics
Roche unlocks new horizons for genomic research in Asia Pacific
Roche is advancing its next-generation sequencing (NGS) ambitions in Asia Pacific following the global launch of AXELIOS 1 in June […]
MoreNews - Pharmaceuticals
‘Unexpected and surprising’: Novartis Lp(a) setback raises tough questions for Amgen and Lilly
The failure of Novartis’ lipoprotein(a) [Lp(a)] therapy to translate substantial biomarker reductions into meaningful cardiovascular benefits has been met with […]
MoreNews - MedTech & Diagnostics
More public hospitals turn to same-day hip and knee surgery, but key blind spots persist
Same-day hip and knee replacements to ease surgical waiting lists are being trialled at The Royal Adelaide Hospital (RAH), but […]
MoreNews - Pharmaceuticals
TGA approves oral Wegovy, prompting questions over efficacy and clinical positioning
The Therapeutic Goods Administration (TGA) approval of Novo Nordisk’s oral GLP-1 receptor agonist Wegovy (semaglutide) is introducing a new dimension to […]
More